

| Rank | Gene Set | Z-score |
|---|---|---|
| 1 | sarcomere organization (GO:0045214) | 7.82985290 |
| 2 | regulation of relaxation of muscle (GO:1901077) | 7.24322645 |
| 3 | cardiac myofibril assembly (GO:0055003) | 7.21895738 |
| 4 | negative regulation of potassium ion transmembrane transporter activity (GO:1901017) | 7.15351886 |
| 5 | negative regulation of potassium ion transmembrane transport (GO:1901380) | 6.56411483 |
| 6 | sarcoplasmic reticulum calcium ion transport (GO:0070296) | 6.56387455 |
| 7 | regulation of sarcomere organization (GO:0060297) | 6.48217726 |
| 8 | myofibril assembly (GO:0030239) | 6.40885218 |
| 9 | regulation of cardiac muscle contraction by regulation of the release of sequestered calcium ion (GO | 6.19062726 |
| 10 | tricarboxylic acid cycle (GO:0006099) | 6.18046179 |
| 11 | regulation of release of sequestered calcium ion into cytosol by sarcoplasmic reticulum (GO:0010880) | 5.94974521 |
| 12 | actin-myosin filament sliding (GO:0033275) | 5.92075302 |
| 13 | muscle filament sliding (GO:0030049) | 5.92075302 |
| 14 | positive regulation of ryanodine-sensitive calcium-release channel activity (GO:0060316) | 5.88597404 |
| 15 | cardiac muscle contraction (GO:0060048) | 5.78658853 |
| 16 | plasma membrane repair (GO:0001778) | 5.69644859 |
| 17 | regulation of actin filament-based movement (GO:1903115) | 5.65115611 |
| 18 | cardiac muscle hypertrophy (GO:0003300) | 5.63645280 |
| 19 | cardiac muscle cell development (GO:0055013) | 5.53703292 |
| 20 | regulation of cardiac muscle contraction by calcium ion signaling (GO:0010882) | 5.45645352 |
| 21 | striated muscle hypertrophy (GO:0014897) | 5.36261161 |
| 22 | adult heart development (GO:0007512) | 5.24291610 |
| 23 | cardiac cell development (GO:0055006) | 5.16393110 |
| 24 | regulation of acetyl-CoA biosynthetic process from pyruvate (GO:0010510) | 5.15414767 |
| 25 | heart trabecula formation (GO:0060347) | 5.13405835 |
| 26 | mitochondrial electron transport, NADH to ubiquinone (GO:0006120) | 5.02460426 |
| 27 | regulation of cell communication by electrical coupling (GO:0010649) | 4.99370291 |
| 28 | ventricular cardiac muscle cell action potential (GO:0086005) | 4.99006547 |
| 29 | creatine metabolic process (GO:0006600) | 4.97343952 |
| 30 | regulation of ventricular cardiac muscle cell membrane repolarization (GO:0060307) | 4.92203398 |
| 31 | actomyosin structure organization (GO:0031032) | 4.90545531 |
| 32 | actin-mediated cell contraction (GO:0070252) | 4.87665443 |
| 33 | regulation of ryanodine-sensitive calcium-release channel activity (GO:0060314) | 4.82373458 |
| 34 | regulation of skeletal muscle contraction (GO:0014819) | 4.81193656 |
| 35 | regulation of acyl-CoA biosynthetic process (GO:0050812) | 4.77222840 |
| 36 | bundle of His cell to Purkinje myocyte communication (GO:0086069) | 4.76275076 |
| 37 | cardiac muscle hypertrophy in response to stress (GO:0014898) | 4.75970446 |
| 38 | muscle hypertrophy in response to stress (GO:0003299) | 4.75970446 |
| 39 | cardiac muscle adaptation (GO:0014887) | 4.75970446 |
| 40 | muscle hypertrophy (GO:0014896) | 4.71632463 |
| 41 | mitochondrial ATP synthesis coupled proton transport (GO:0042776) | 4.71023731 |
| 42 | regulation of striated muscle contraction (GO:0006942) | 4.67068584 |
| 43 | cardiac muscle tissue morphogenesis (GO:0055008) | 4.64484003 |
| 44 | striated muscle contraction (GO:0006941) | 4.61906731 |
| 45 | respiratory electron transport chain (GO:0022904) | 4.60678506 |
| 46 | regulation of membrane repolarization (GO:0060306) | 4.59838323 |
| 47 | regulation of the force of heart contraction (GO:0002026) | 4.52928394 |
| 48 | muscle adaptation (GO:0043500) | 4.50842285 |
| 49 | ventricular cardiac muscle tissue morphogenesis (GO:0055010) | 4.50387863 |
| 50 | electron transport chain (GO:0022900) | 4.46359853 |
| 51 | regulation of cardiac muscle cell contraction (GO:0086004) | 4.43792348 |
| 52 | ATP synthesis coupled proton transport (GO:0015986) | 4.41409490 |
| 53 | energy coupled proton transport, down electrochemical gradient (GO:0015985) | 4.41409490 |
| 54 | regulation of coenzyme metabolic process (GO:0051196) | 4.31272362 |
| 55 | regulation of cofactor metabolic process (GO:0051193) | 4.31272362 |
| 56 | cell communication involved in cardiac conduction (GO:0086065) | 4.28533618 |
| 57 | carnitine shuttle (GO:0006853) | 4.24037928 |
| 58 | regulation of cardiac muscle contraction (GO:0055117) | 4.21268214 |
| 59 | muscle tissue morphogenesis (GO:0060415) | 4.20444577 |
| 60 | negative regulation of protein localization to cell surface (GO:2000009) | 4.19768351 |
| 61 | cell communication by electrical coupling involved in cardiac conduction (GO:0086064) | 4.05844700 |
| 62 | striated muscle atrophy (GO:0014891) | 4.00196028 |
| 63 | relaxation of cardiac muscle (GO:0055119) | 3.95194396 |
| 64 | heart process (GO:0003015) | 3.93969946 |
| 65 | heart contraction (GO:0060047) | 3.93969946 |
| 66 | skeletal muscle adaptation (GO:0043501) | 3.92764806 |
| 67 | negative regulation of potassium ion transport (GO:0043267) | 3.82950704 |
| 68 | negative regulation of calcium ion transmembrane transporter activity (GO:1901020) | 3.80005480 |
| 69 | negative regulation of calcium ion transmembrane transport (GO:1903170) | 3.80005480 |
| 70 | pinocytosis (GO:0006907) | 3.76065898 |
| 71 | NADH metabolic process (GO:0006734) | 3.75910835 |
| 72 | response to inactivity (GO:0014854) | 3.74406624 |
| 73 | fatty acid transmembrane transport (GO:1902001) | 3.72592163 |
| 74 | regulation of ATPase activity (GO:0043462) | 3.72224688 |
| 75 | regulation of ATP catabolic process (GO:1903289) | 3.72224688 |
| 76 | 2-oxoglutarate metabolic process (GO:0006103) | 3.68761079 |
| 77 | regulation of calcium ion transmembrane transport (GO:1903169) | 3.67766440 |
| 78 | regulation of calcium ion transmembrane transporter activity (GO:1901019) | 3.67766440 |
| 79 | actin filament-based movement (GO:0030048) | 3.66800728 |
| 80 | striated muscle adaptation (GO:0014888) | 3.64888224 |
| 81 | muscle atrophy (GO:0014889) | 3.62974579 |
| 82 | response to stimulus involved in regulation of muscle adaptation (GO:0014874) | 3.62428981 |
| 83 | regulation of sulfur metabolic process (GO:0042762) | 3.61744939 |
| 84 | regulation of sequestering of triglyceride (GO:0010889) | 3.59523980 |
| 85 | response to muscle activity (GO:0014850) | 3.59308916 |
| 86 | positive regulation of calcium ion transmembrane transporter activity (GO:1901021) | 3.59291570 |
| 87 | negative regulation of cardiac muscle hypertrophy (GO:0010614) | 3.55208611 |
| 88 | ventricular cardiac muscle cell development (GO:0055015) | 3.54630648 |
| 89 | potassium ion export (GO:0071435) | 3.52919410 |
| 90 | cardiac muscle cell action potential involved in contraction (GO:0086002) | 3.51735645 |
| 91 | regulation of heart rate (GO:0002027) | 3.51679191 |
| 92 | cell communication by electrical coupling (GO:0010644) | 3.51333659 |
| 93 | positive regulation of cation channel activity (GO:2001259) | 3.50320244 |
| 94 | cardiac muscle cell action potential (GO:0086001) | 3.48097862 |
| 95 | pathway-restricted SMAD protein phosphorylation (GO:0060389) | 3.47888902 |
| 96 | detection of calcium ion (GO:0005513) | 3.46780608 |
| 97 | cardiac muscle cell proliferation (GO:0060038) | 3.46715476 |
| 98 | cardiac conduction (GO:0061337) | 3.46445635 |
| 99 | skeletal muscle contraction (GO:0003009) | 3.45866645 |
| 100 | oxidative phosphorylation (GO:0006119) | 3.45374721 |
| 101 | positive regulation of heart rate (GO:0010460) | 3.45262435 |
| 102 | regulation of heart contraction (GO:0008016) | 3.43420322 |
| 103 | atrioventricular valve morphogenesis (GO:0003181) | 3.38079339 |
| 104 | regulation of phospholipid biosynthetic process (GO:0071071) | 3.37951165 |
| 105 | receptor guanylyl cyclase signaling pathway (GO:0007168) | 3.31205333 |
| 106 | carnitine transmembrane transport (GO:1902603) | 3.29953690 |
| 107 | succinate metabolic process (GO:0006105) | 3.29881570 |
| 108 | oxygen transport (GO:0015671) | 3.28381973 |
| 109 | focal adhesion assembly (GO:0048041) | 3.27126334 |
| 110 | cell-substrate adherens junction assembly (GO:0007045) | 3.27126334 |
| 111 | fatty acid beta-oxidation (GO:0006635) | 3.25969585 |
| 112 | adrenergic receptor signaling pathway (GO:0071875) | 3.24696303 |
| 113 | regulation of cardioblast differentiation (GO:0051890) | 3.24623851 |
| 114 | negative regulation of muscle hypertrophy (GO:0014741) | 3.23604166 |
| 115 | striated muscle cell development (GO:0055002) | 3.23401751 |
| 116 | regulation of cell proliferation involved in heart morphogenesis (GO:2000136) | 3.12264175 |
| 117 | muscle contraction (GO:0006936) | 3.09449992 |
| 118 | negative regulation of necroptotic process (GO:0060546) | 3.09370133 |
| 119 | response to caffeine (GO:0031000) | 3.03784238 |
| 120 | positive regulation of membrane protein ectodomain proteolysis (GO:0051044) | 2.95013877 |
| 121 | muscle system process (GO:0003012) | 2.93892999 |
| 122 | striated muscle cell proliferation (GO:0014855) | 2.91948355 |
| 123 | regulation of acrosome reaction (GO:0060046) | 2.91864582 |
| 124 | regulation of female gonad development (GO:2000194) | 2.87381237 |
| 125 | regulation of NFAT protein import into nucleus (GO:0051532) | 2.85559924 |
| 126 | atrial septum morphogenesis (GO:0060413) | 2.83012230 |
| 127 | positive regulation of cardiac muscle hypertrophy (GO:0010613) | 2.80457437 |
| 128 | positive regulation of muscle hypertrophy (GO:0014742) | 2.80457437 |
| 129 | adherens junction assembly (GO:0034333) | 2.80006750 |
| 130 | activation of MAPKKK activity (GO:0000185) | 2.79797874 |
| 131 | glucose 6-phosphate metabolic process (GO:0051156) | 2.77557353 |
| 132 | regulation of cholesterol storage (GO:0010885) | 2.76854261 |
| 133 | regulation of membrane protein ectodomain proteolysis (GO:0051043) | 2.70779835 |
| 134 | negative regulation of heart growth (GO:0061117) | 2.68702673 |
| 135 | negative regulation of cardiac muscle tissue growth (GO:0055022) | 2.68702673 |
| 136 | response to epinephrine (GO:0071871) | 2.67660370 |

| Rank | Gene Set | Z-score |
|---|---|---|
| 1 | PPARG_19300518_ChIP-PET_3T3-L1_Mouse | 4.99049920 |
| 2 | EZH2_22144423_ChIP-Seq_EOC_Human | 4.13784784 |
| 3 | EP300_21415370_ChIP-Seq_HL-1_Mouse | 3.92050410 |
| 4 | ESRRB_18555785_ChIP-Seq_MESCs_Mouse | 3.43174777 |
| 5 | NUCKS1_24931609_ChIP-Seq_HEPATOCYTES_Mouse | 3.03164457 |
| 6 | TBX20_22328084_ChIP-Seq_HEART_Mouse | 2.98136751 |
| 7 | TBX20_22080862_ChIP-Seq_HEART_Mouse | 2.98136751 |
| 8 | TAF7L_23326641_ChIP-Seq_C3H10T1-2_Mouse | 2.81863668 |
| 9 | RUNX1_26923725_Chip-Seq_MACROPHAGESS_Mouse | 2.55989749 |
| 10 | CTNNB1_24651522_ChIP-Seq_LGR5+_INTESTINAL_STEM_Human | 2.42798615 |
| 11 | ESR1_20079471_ChIP-ChIP_T-47D_Human | 2.41955160 |
| 12 | TRP63_18441228_ChIP-ChIP_KERATINOCYTES_Mouse | 2.25659336 |
| 13 | CDX2_19796622_ChIP-Seq_MESCs_Mouse | 2.13528449 |
| 14 | ELK3_25401928_ChIP-Seq_HUVEC_Human | 2.13268984 |
| 15 | MEF2A_21415370_ChIP-Seq_HL-1_Mouse | 1.98456468 |
| 16 | RACK7_27058665_Chip-Seq_MCF-7_Human | 1.95254920 |
| 17 | NR1H3_23393188_ChIP-Seq_ATHEROSCLEROTIC-FOAM_Human | 1.94356378 |
| 18 | SUZ12_18555785_ChIP-Seq_MESCs_Mouse | 1.93108942 |
| 19 | NFIB_24661679_ChIP-Seq_LUNG_Mouse | 1.91747623 |
| 20 | LXR_22292898_ChIP-Seq_THP-1_Human | 1.85002035 |
| 21 | GATA1_22025678_ChIP-Seq_K562_Human | 1.83232502 |
| 22 | TRIM28_21343339_ChIP-Seq_HEK293_Human | 1.81531100 |
| 23 | PRDM16_22522345_ChIP-ChIP_PALATE_MESENCHYMAL_Mouse | 1.79287525 |
| 24 | KDM2B_26808549_Chip-Seq_SUP-B15_Human | 1.75684837 |
| 25 | ZFP281_18358816_ChIP-ChIP_MESCs_Mouse | 1.73474246 |
| 26 | DROSHA_22980978_ChIP-Seq_HELA_Human | 1.67147976 |
| 27 | KLF6_26769127_Chip-Seq_PDAC-Cell_line_Human | 1.62904366 |
| 28 | SUZ12_18692474_ChIP-Seq_MESCs_Mouse | 1.61937712 |
| 29 | VDR_22108803_ChIP-Seq_LS180_Human | 1.61873773 |
| 30 | RUNX2_24764292_ChIP-Seq_MC3T3_Mouse | 1.61269807 |
| 31 | RXR_22158963_ChIP-Seq_LIVER_Mouse | 1.59964452 |
| 32 | SUZ12_18692474_ChIP-Seq_MEFs_Mouse | 1.57882398 |
| 33 | ESR1_21235772_ChIP-Seq_MCF-7_Human | 1.56611834 |
| 34 | MTF2_20144788_ChIP-Seq_MESCs_Mouse | 1.55152118 |
| 35 | TCF7_22412390_ChIP-Seq_EML_Mouse | 1.55137342 |
| 36 | KDM2B_26808549_Chip-Seq_K562_Human | 1.55035996 |
| 37 | ATF3_27146783_Chip-Seq_COLON_Human | 1.54618401 |
| 38 | PPARA_22158963_ChIP-Seq_LIVER_Mouse | 1.54111309 |
| 39 | RARG_19884340_ChIP-ChIP_MEFs_Mouse | 1.53242008 |
| 40 | NR0B1_18358816_ChIP-ChIP_MESCs_Mouse | 1.52587006 |
| 41 | ZFP281_18757296_ChIP-ChIP_E14_Mouse | 1.51907077 |
| 42 | TBP_23326641_ChIP-Seq_C3H10T1-2_Mouse | 1.51440529 |
| 43 | THRA_23701648_ChIP-Seq_CEREBELLUM_Mouse | 1.50287688 |
| 44 | RELA_24523406_ChIP-Seq_FIBROSARCOMA_Human | 1.49380177 |
| 45 | KLF4_26769127_Chip-Seq_PDAC-Cell_line_Human | 1.49311072 |
| 46 | EZH2_18974828_ChIP-Seq_MESCs_Mouse | 1.49098523 |
| 47 | RNF2_18974828_ChIP-Seq_MESCs_Mouse | 1.49098523 |
| 48 | P300_27058665_Chip-Seq_ZR-75-30cells_Human | 1.48332202 |
| 49 | KDM2B_26808549_Chip-Seq_SIL-ALL_Human | 1.46810126 |
| 50 | EP300_20729851_ChIP-Seq_FORBRAIN_MIDBRAIN_LIMB_HEART_Mouse | 1.46052147 |
| 51 | KDM2B_26808549_Chip-Seq_DND41_Human | 1.40660194 |
| 52 | TP63_17297297_ChIP-ChIP_HaCaT_Human | 1.39139168 |
| 53 | EZH2_27294783_Chip-Seq_ESCs_Mouse | 1.39022817 |
| 54 | HIF1A_21447827_ChIP-Seq_MCF-7_Human | 1.38637084 |
| 55 | NR3C1_23031785_ChIP-Seq_PC12_Mouse | 1.37470993 |
| 56 | ZNF274_21170338_ChIP-Seq_K562_Hela | 1.36829813 |
| 57 | EZH2_27304074_Chip-Seq_ESCs_Mouse | 1.36593463 |
| 58 | PPARD_23208498_ChIP-Seq_MDA-MB-231_Human | 1.36055573 |
| 59 | SUZ12_20075857_ChIP-Seq_MESCs_Mouse | 1.36013608 |
| 60 | GATA4_21415370_ChIP-Seq_HL-1_Mouse | 1.35645601 |
| 61 | SMAD3_22036565_ChIP-Seq_ESCs_Mouse | 1.35616099 |
| 62 | BACH1_22875853_ChIP-PCR_HELA_AND_SCP4_Human | 1.33776458 |
| 63 | GATA2_26923725_Chip-Seq_HEMANGIOBLAST_Mouse | 1.33534049 |
| 64 | GBX2_23144817_ChIP-Seq_PC3_Human | 1.32984432 |
| 65 | GATA1_19941827_ChIP-Seq_MEL_Mouse | 1.32191172 |
| 66 | LXR_22158963_ChIP-Seq_LIVER_Mouse | 1.31588275 |
| 67 | AR_21572438_ChIP-Seq_LNCaP_Human | 1.31050083 |
| 68 | SMARCA4_20176728_ChIP-ChIP_TSCs_Mouse | 1.30860065 |
| 69 | ESR1_22446102_ChIP-Seq_UTERUS_Mouse | 1.30209361 |
| 70 | TCFAP2C_20176728_ChIP-ChIP_TROPHOBLAST_STEM_CELLS_Mouse | 1.29349650 |
| 71 | JARID2_20064375_ChIP-Seq_MESCs_Mouse | 1.29156481 |
| 72 | ZNF263_19887448_ChIP-Seq_K562_Human | 1.28928241 |
| 73 | VDR_21846776_ChIP-Seq_THP-1_Human | 1.28404739 |
| 74 | NR1I2_20693526_ChIP-Seq_LIVER_Mouse | 1.28400404 |
| 75 | UBF1/2_26484160_Chip-Seq_HMEC-DERIVED_Human | 1.28340296 |
| 76 | GATA3_20176728_ChIP-ChIP_TSCs_Mouse | 1.28106261 |
| 77 | STAT3_22323479_ChIP-Seq_MACROPHAGE_Mouse | 1.26404637 |
| 78 | TCF21_23034159_ChIP-ChIP_E13_GONADS_Rat | 1.26324737 |
| 79 | EZH2_23942234_ChIP-Seq_MYOBLASTS_AND_MYOTUBES_Mouse | 1.24939976 |
| 80 | WT1_20215353_ChIP-ChIP_NEPHRON_PROGENITOR_Mouse | 1.24687074 |
| 81 | SMC4_20622854_ChIP-Seq_HELA_Human | 1.20541187 |
| 82 | DACH1_20351289_ChIP-Seq_MDA-MB-231_Human | 1.20052937 |
| 83 | TFAP2C_20629094_ChIP-Seq_MCF-7_Human | 1.19974141 |
| 84 | STAT3_1855785_ChIP-Seq_MESCs_Mouse | 1.19732074 |
| 85 | BP1_19119308_ChIP-ChIP_Hs578T_Human | 1.19529747 |
| 86 | CEBPB_21427703_ChIP-Seq_3T3-L1_Mouse | 1.17125649 |
| 87 | SUZ12_18974828_ChIP-Seq_MESCs_Mouse | 1.15993598 |
| 88 | SOX9_24532713_ChIP-Seq_HFSC_Mouse | 1.15558238 |
| 89 | SOX2_21211035_ChIP-Seq_LN229_Gbm | 1.15038488 |
| 90 | EGR1_20690147_ChIP-Seq_ERYTHROLEUKEMIA_Human | 1.14279069 |
| 91 | SMAD4_21799915_ChIP-Seq_A2780_Human | 1.13536480 |
| 92 | MYC_22102868_ChIP-Seq_BL_Human | 1.13441762 |
| 93 | ERG_21242973_ChIP-ChIP_JURKAT_Human | 1.12483724 |
| 94 | STAT3_19079543_ChIP-ChIP_MESCs_Mouse | 1.12101342 |
| 95 | RARB_27405468_Chip-Seq_BRAIN_Mouse | 1.12003639 |
| 96 | GATA2_21666600_ChIP-Seq_HMVEC_Human | 1.11138695 |
| 97 | STAT6_21828071_ChIP-Seq_BEAS2B_Human | 1.10658636 |
| 98 | AR_21909140_ChIP-Seq_LNCAP_Human | 1.10524269 |
| 99 | ZNF652_21678463_ChIP-ChIP_ZR75-1_Human | 1.10048462 |
| 100 | P68_20966046_ChIP-Seq_HELA_Human | 1.09445111 |
| 101 | ESR2_21235772_ChIP-Seq_MCF-7_Human | 1.08757266 |
| 102 | JARID2_20075857_ChIP-Seq_MESCs_Mouse | 1.07315330 |
| 103 | SRY_22984422_ChIP-ChIP_TESTIS_Rat | 1.07279203 |
| 104 | SUZ12_16625203_ChIP-ChIP_MESCs_Mouse | 1.07109246 |
| 105 | SMARCA4_23332759_ChIP-Seq_OLIGODENDROCYTES_Mouse | 1.06096458 |
| 106 | SMAD3_21741376_ChIP-Seq_HESCs_Human | 1.05778225 |
| 107 | SREBP1_19666523_ChIP-Seq_LIVER_Mouse | 1.05601869 |
| 108 | CTCF_27219007_Chip-Seq_Bcells_Human | 1.05297623 |
| 109 | WT1_25993318_ChIP-Seq_PODOCYTE_Human | 1.05217144 |
| 110 | SUZ12_27294783_Chip-Seq_ESCs_Mouse | 1.03280310 |
| 111 | CTCF_27219007_Chip-Seq_ERYTHROID_Human | 1.03168786 |
| 112 | SALL4_18804426_ChIP-ChIP_XEN_Mouse | 1.02043650 |
| 113 | SMAD4_21741376_ChIP-Seq_HESCs_Human | 1.01157417 |
| 114 | TET1_21451524_ChIP-Seq_MESCs_Mouse | 1.00558408 |
| 115 | KLF4_18358816_ChIP-ChIP_MESCs_Mouse | 0.99858264 |
| 116 | EED_16625203_ChIP-ChIP_MESCs_Mouse | 0.99355536 |
| 117 | KLF4_18555785_ChIP-Seq_MESCs_Mouse | 0.99329101 |
| 118 | SMC1_22415368_ChIP-Seq_MEFs_Mouse | 0.98600456 |
| 119 | HSF1_23293686_ChIP-Seq_STHDH_STRIATAL_Mouse | 0.97920824 |
| 120 | FOXM1_23109430_ChIP-Seq_U2OS_Human | 0.97587873 |
| 121 | RNF2_27304074_Chip-Seq_ESCs_Mouse | 0.96752922 |
| 122 | UBF1/2_26484160_Chip-Seq_HMECs_Human | 0.96675419 |
| 123 | SMC3_22415368_ChIP-Seq_MEFs_Mouse | 0.95696947 |
| 124 | RCOR2_21632747_ChIP-Seq_MESCs_Mouse | 0.95403880 |
| 125 | NANOG_21062744_ChIP-ChIP_HESCs_Human | 0.95008887 |
| 126 | PBX_27287812_Chip-Seq_EMBYONIC-LIMB_Mouse | 0.94930067 |
| 127 | CTNNB1_20460455_ChIP-Seq_HCT116_Human | 0.94782710 |
| 128 | SMAD3_18955504_ChIP-ChIP_HaCaT_Human | 0.94366397 |
| 129 | PPARD_23176727_ChIP-Seq_KERATINOCYTES_Mouse | 0.92303350 |
| 130 | BCAT_22108803_ChIP-Seq_LS180_Human | 0.91769963 |
| 131 | GATA1_19941826_ChIP-Seq_K562_Human | 0.91411670 |
| 132 | AHR_22903824_ChIP-Seq_MCF-7_Human | 0.91311294 |
| 133 | DNAJC2_21179169_ChIP-ChIP_NT2_Human | 0.90827651 |
| 134 | PIAS1_25552417_ChIP-Seq_VCAP_Human | 0.89993907 |
| 135 | PAX3-FKHR_20663909_ChIP-Seq_RHABDOMYOSARCOMA_Human | 0.89975257 |
| 136 | CREB1_26743006_Chip-Seq_LNCaP-abl_Human | 0.88686807 |
| 137 | EGR1_19032775_ChIP-ChIP_M12_Human | 0.87314126 |
| 138 | ISL1_27105846_Chip-Seq_CPCs_Mouse | 0.87269835 |
| 139 | SMAD2/3_21741376_ChIP-Seq_EPCs_Human | 0.86915508 |
| 140 | TCF4_18268006_ChIP-ChIP_LS174T_Human | 0.86664353 |
| 141 | PPAR_26484153_Chip-Seq_NCI-H1993_Human | 0.86414057 |
| 142 | SOX9_25088423_ChIP-ChIP_EMBRYONIC_GONADS_Mouse | 0.86047435 |
| 143 | NRF2_20460467_ChIP-Seq_MEFs_Mouse | 0.85610161 |
| 144 | NFE2L2_20460467_ChIP-Seq_MEFs_Mouse | 0.85610161 |
| 145 | CJUN_26792858_Chip-Seq_BT549_Human | 0.85594791 |
| 146 | FOXO1_23066095_ChIP-Seq_LIVER_Mouse | 0.85411348 |
| 147 | ARNT_22903824_ChIP-Seq_MCF-7_Human | 0.85248579 |
| 148 | NKX2-5_21415370_ChIP-Seq_HL-1_Mouse | 0.85194417 |
| 149 | TBL1_22424771_ChIP-Seq_293T_Human | 0.83127448 |
| 150 | SMAD3_21741376_ChIP-Seq_EPCs_Human | 0.82684626 |
| 151 | TEAD4_22529382_ChIP-Seq_TROPHECTODERM_Mouse | 0.82209231 |
| 152 | UBF1/2_26484160_Chip-Seq_FIBROBLAST_Human | 0.81993328 |
| 153 | TRIM28_17542650_ChIP-ChIP_NTERA2_Human | 0.81912980 |
| 154 | CLOCK_20551151_ChIP-Seq_293T_Human | 0.81750925 |
| 155 | TCF21_26020271_ChIP-Seq_SMOOTH_MUSCLE_Human | 0.81505293 |
| 156 | ESR1_17901129_ChIP-ChIP_LIVER_Mouse | 0.80287309 |
| 157 | REST_18959480_ChIP-ChIP_MESCs_Mouse | 0.79872194 |
| 158 | TP63_22573176_ChIP-Seq_HFKS_Human | 0.79681598 |
| 159 | FOXA2_19822575_ChIP-Seq_HepG2_Human | 0.79252483 |
| 160 | TCF3/E2A_22897851_ChIP-Seq_JUKARTE6-1_Human | 0.78960940 |
| 161 | GATA1_19941827_ChIP-Seq_MEL86_Mouse | 0.77948240 |
| 162 | STAT3_23295773_ChIP-Seq_U87_Human | 0.77422527 |
| 163 | OCT4_20526341_ChIP-Seq_ESCs_Human | 0.77412041 |
| 164 | MEIS1_26923725_Chip-Seq_HEMOGENIC-ENDOTHELIUM_Mouse | 0.77382264 |
| 165 | KLF4_19829295_ChIP-Seq_ESCs_Human | 0.77262406 |
| 166 | AUTS2_25519132_ChIP-Seq_293T-REX_Human | 0.76755121 |

| Rank | Gene Set | Z-score |
|---|---|---|
| 1 | MP0002837_dystrophic_cardiac_calcinosis | 5.98791721 |
| 2 | MP0003646_muscle_fatigue | 5.69182232 |
| 3 | MP0000751_myopathy | 5.42686174 |
| 4 | MP0004084_abnormal_cardiac_muscle | 5.32644194 |
| 5 | MP0004215_abnormal_myocardial_fiber | 4.67902857 |
| 6 | MP0004036_abnormal_muscle_relaxation | 4.02630939 |
| 7 | MP0000749_muscle_degeneration | 3.85362106 |
| 8 | MP0005330_cardiomyopathy | 3.75217843 |
| 9 | MP0008775_abnormal_heart_ventricle | 3.16199989 |
| 10 | MP0002972_abnormal_cardiac_muscle | 3.10529188 |
| 11 | MP0004484_altered_response_of | 3.01080295 |
| 12 | MP0004087_abnormal_muscle_fiber | 2.95087142 |
| 13 | MP0003137_abnormal_impulse_conducting | 2.79640265 |
| 14 | MP0005620_abnormal_muscle_contractility | 2.60785938 |
| 15 | MP0009840_abnormal_foam_cell | 2.60592453 |
| 16 | MP0004130_abnormal_muscle_cell | 2.60567284 |
| 17 | MP0001544_abnormal_cardiovascular_syste | 2.57237976 |
| 18 | MP0005385_cardiovascular_system_phenoty | 2.57237976 |
| 19 | MP0000750_abnormal_muscle_regeneration | 2.56440999 |
| 20 | MP0002106_abnormal_muscle_physiology | 2.45847706 |
| 21 | MP0004145_abnormal_muscle_electrophysio | 2.37001547 |
| 22 | MP0006138_congestive_heart_failure | 2.34155897 |
| 23 | MP0010630_abnormal_cardiac_muscle | 2.31213871 |
| 24 | MP0004085_abnormal_heartbeat | 2.28643877 |
| 25 | MP0002269_muscular_atrophy | 2.15971874 |
| 26 | MP0000747_muscle_weakness | 2.14145039 |
| 27 | MP0003828_pulmonary_edema | 2.09004564 |
| 28 | MP0005369_muscle_phenotype | 2.01088459 |
| 29 | MP0003221_abnormal_cardiomyocyte_apopto | 1.97562576 |
| 30 | MP0006036_abnormal_mitochondrial_physio | 1.95608476 |
| 31 | MP0000759_abnormal_skeletal_muscle | 1.95270579 |
| 32 | MP0003950_abnormal_plasma_membrane | 1.82316612 |
| 33 | MP0004510_myositis | 1.81709241 |
| 34 | MP0008004_abnormal_stomach_pH | 1.76673815 |
| 35 | MP0002332_abnormal_exercise_endurance | 1.71379154 |
| 36 | MP0002127_abnormal_cardiovascular_syste | 1.53048528 |
| 37 | MP0005076_abnormal_cell_differentiation | 1.45231099 |
| 38 | MP0005666_abnormal_adipose_tissue | 1.41718918 |
| 39 | MP0004233_abnormal_muscle_weight | 1.41615692 |
| 40 | MP0004185_abnormal_adipocyte_glucose | 1.29414733 |
| 41 | MP0010030_abnormal_orbit_morphology | 1.25992399 |
| 42 | MP0005165_increased_susceptibility_to | 1.25503951 |
| 43 | MP0005058_abnormal_lysosome_morphology | 1.17531274 |
| 44 | MP0000343_altered_response_to | 1.14887765 |
| 45 | MP0002139_abnormal_hepatobiliary_system | 1.11957894 |
| 46 | MP0004043_abnormal_pH_regulation | 1.04773148 |
| 47 | MP0001661_extended_life_span | 1.02438783 |
| 48 | MP0000266_abnormal_heart_morphology | 1.01718642 |
| 49 | MP0005375_adipose_tissue_phenotype | 1.01251702 |
| 50 | MP0002234_abnormal_pharynx_morphology | 0.99583541 |
| 51 | MP0006035_abnormal_mitochondrial_morpho | 0.99117350 |
| 52 | MP0000230_abnormal_systemic_arterial | 0.98589085 |
| 53 | MP0003705_abnormal_hypodermis_morpholog | 0.97014977 |
| 54 | MP0003453_abnormal_keratinocyte_physiol | 0.95733752 |
| 55 | MP0003303_peritoneal_inflammation | 0.93169301 |
| 56 | MP0002089_abnormal_postnatal_growth/wei | 0.89971118 |
| 57 | MP0002108_abnormal_muscle_morphology | 0.87193084 |
| 58 | MP0003567_abnormal_fetal_cardiomyocyte | 0.85107053 |
| 59 | MP0001849_ear_inflammation | 0.84790825 |
| 60 | MP0005451_abnormal_body_composition | 0.81760733 |
| 61 | MP0005670_abnormal_white_adipose | 0.80396572 |
| 62 | MP0005266_abnormal_metabolism | 0.80227848 |
| 63 | MP0010368_abnormal_lymphatic_system | 0.79100973 |
| 64 | MP0003880_abnormal_central_pattern | 0.77297411 |
| 65 | MP0002971_abnormal_brown_adipose | 0.73856862 |
| 66 | MP0000013_abnormal_adipose_tissue | 0.73014502 |
| 67 | MP0001730_embryonic_growth_arrest | 0.73013625 |
| 68 | MP0000003_abnormal_adipose_tissue | 0.72297074 |
| 69 | MP0005187_abnormal_penis_morphology | 0.70781148 |
| 70 | MP0001529_abnormal_vocalization | 0.69611240 |
| 71 | MP0002877_abnormal_melanocyte_morpholog | 0.67696996 |
| 72 | MP0005535_abnormal_body_temperature | 0.66517038 |
| 73 | MP0003984_embryonic_growth_retardation | 0.66373335 |
| 74 | MP0001915_intracranial_hemorrhage | 0.65008422 |
| 75 | MP0004924_abnormal_behavior | 0.63788628 |
| 76 | MP0005386_behavior/neurological_phenoty | 0.63788628 |
| 77 | MP0005023_abnormal_wound_healing | 0.63267174 |
| 78 | MP0002909_abnormal_adrenal_gland | 0.63209523 |
| 79 | MP0004859_abnormal_synaptic_plasticity | 0.62719018 |
| 80 | MP0004147_increased_porphyrin_level | 0.61853764 |
| 81 | MP0002088_abnormal_embryonic_growth/wei | 0.61439294 |
| 82 | MP0009278_abnormal_bone_marrow | 0.61290747 |
| 83 | MP0002925_abnormal_cardiovascular_devel | 0.61134049 |
| 84 | MP0005409_darkened_coat_color | 0.61121473 |
| 85 | MP0002998_abnormal_bone_remodeling | 0.60937835 |
| 86 | MP0002822_catalepsy | 0.60545902 |
| 87 | MP0003566_abnormal_cell_adhesion | 0.60010541 |
| 88 | MP0002128_abnormal_blood_circulation | 0.59432060 |
| 89 | MP0003091_abnormal_cell_migration | 0.58811937 |
| 90 | MP0000566_synostosis | 0.58578686 |
| 91 | MP0005167_abnormal_blood-brain_barrier | 0.58408869 |
| 92 | MP0002078_abnormal_glucose_homeostasis | 0.57482761 |
| 93 | MP0003718_maternal_effect | 0.56801860 |
| 94 | MP0005380_embryogenesis_phenotype | 0.56440281 |
| 95 | MP0001672_abnormal_embryogenesis/_devel | 0.56440281 |
| 96 | MP0008260_abnormal_autophagy | 0.55976456 |
| 97 | MP0005623_abnormal_meninges_morphology | 0.53193086 |
| 98 | MP0000579_abnormal_nail_morphology | 0.52520587 |
| 99 | MP0004270_analgesia | 0.52451738 |
| 100 | MP0008961_abnormal_basal_metabolism | 0.52301318 |
| 101 | MP0003329_amyloid_beta_deposits | 0.51516358 |
| 102 | MP0000733_abnormal_muscle_development | 0.48940898 |
| 103 | MP0002295_abnormal_pulmonary_circulatio | 0.48700892 |
| 104 | MP0009115_abnormal_fat_cell | 0.47684053 |
| 105 | MP0004272_abnormal_basement_membrane | 0.47648202 |
| 106 | MP0001614_abnormal_blood_vessel | 0.46224870 |
| 107 | MP0002163_abnormal_gland_morphology | 0.46214798 |
| 108 | MP0002272_abnormal_nervous_system | 0.45255959 |
| 109 | MP0001440_abnormal_grooming_behavior | 0.44650656 |
| 110 | MP0002896_abnormal_bone_mineralization | 0.44401200 |
| 111 | MP0000920_abnormal_myelination | 0.44080497 |
| 112 | MP0003195_calcinosis | 0.43936650 |
| 113 | MP0000767_abnormal_smooth_muscle | 0.42287951 |
| 114 | MP0005595_abnormal_vascular_smooth | 0.41724755 |
| 115 | MP0005257_abnormal_intraocular_pressure | 0.41299393 |
| 116 | MP0003656_abnormal_erythrocyte_physiolo | 0.41201015 |
| 117 | MP0003690_abnormal_glial_cell | 0.41017583 |
| 118 | MP0008569_lethality_at_weaning | 0.40907953 |
| 119 | MP0003075_altered_response_to | 0.40098839 |
| 120 | MP0003806_abnormal_nucleotide_metabolis | 0.39935009 |
| 121 | MP0003635_abnormal_synaptic_transmissio | 0.39523342 |
| 122 | MP0002254_reproductive_system_inflammat | 0.39089414 |
| 123 | MP0001879_abnormal_lymphatic_vessel | 0.38283489 |
| 124 | MP0006072_abnormal_retinal_apoptosis | 0.38136253 |
| 125 | MP0005164_abnormal_response_to | 0.37820267 |
| 126 | MP0005647_abnormal_sex_gland | 0.37321963 |
| 127 | MP0003879_abnormal_hair_cell | 0.36167997 |
| 128 | MP0003279_aneurysm | 0.35924507 |
| 129 | MP0005334_abnormal_fat_pad | 0.35597156 |
| 130 | MP0002064_seizures | 0.35587253 |
| 131 | MP0000249_abnormal_blood_vessel | 0.35357361 |
| 132 | MP0009745_abnormal_behavioral_response | 0.35318488 |
| 133 | MP0000858_altered_metastatic_potential | 0.35115840 |
| 134 | MP0009046_muscle_twitch | 0.35037561 |
| 135 | MP0002080_prenatal_lethality | 0.34785381 |
| 136 | MP0005584_abnormal_enzyme/coenzyme_acti | 0.34752343 |
| 137 | MP0002090_abnormal_vision | 0.34286756 |
| 138 | MP0005319_abnormal_enzyme/_coenzyme | 0.33210206 |
| 139 | MP0002118_abnormal_lipid_homeostasis | 0.32566150 |
| 140 | MP0008874_decreased_physiological_sensi | 0.32274362 |
| 141 | MP0005083_abnormal_biliary_tract | 0.30799974 |
| 142 | MP0004858_abnormal_nervous_system | 0.30646489 |
| 143 | MP0003633_abnormal_nervous_system | 0.30566045 |

| Rank | Gene Set | Z-score |
|---|---|---|
| 1 | Sudden death (HP:0001699) | 7.01035831 |
| 2 | Calf muscle hypertrophy (HP:0008981) | 6.45746697 |
| 3 | Ventricular tachycardia (HP:0004756) | 6.11552169 |
| 4 | Muscle hypertrophy of the lower extremities (HP:0008968) | 6.01143763 |
| 5 | Atrial fibrillation (HP:0005110) | 5.93038475 |
| 6 | Exercise-induced myalgia (HP:0003738) | 5.74637622 |
| 7 | Primary atrial arrhythmia (HP:0001692) | 5.52192307 |
| 8 | Supraventricular tachycardia (HP:0004755) | 5.31458876 |
| 9 | Abnormality of the calf musculature (HP:0001430) | 5.25933250 |
| 10 | Muscle fiber splitting (HP:0003555) | 5.25595726 |
| 11 | Exercise-induced muscle cramps (HP:0003710) | 5.25008252 |
| 12 | Supraventricular arrhythmia (HP:0005115) | 5.18037663 |
| 13 | Hyporeflexia of lower limbs (HP:0002600) | 4.75642867 |
| 14 | Syncope (HP:0001279) | 4.71459224 |
| 15 | Myoglobinuria (HP:0002913) | 4.70102740 |
| 16 | Lipoatrophy (HP:0100578) | 4.67020252 |
| 17 | Bundle branch block (HP:0011710) | 4.63181703 |
| 18 | Right ventricular cardiomyopathy (HP:0011663) | 4.38773634 |
| 19 | Palpitations (HP:0001962) | 4.15576773 |
| 20 | Dilated cardiomyopathy (HP:0001644) | 4.09934882 |
| 21 | Prolonged QT interval (HP:0001657) | 4.09452340 |
| 22 | EMG: myopathic abnormalities (HP:0003458) | 4.05712526 |
| 23 | Asymmetric septal hypertrophy (HP:0001670) | 3.89277579 |
| 24 | Heart block (HP:0012722) | 3.86816241 |
| 25 | Acute necrotizing encephalopathy (HP:0006965) | 3.72163911 |
| 26 | Abnormal mitochondria in muscle tissue (HP:0008316) | 3.69308831 |
| 27 | Abnormality of the left ventricular outflow tract (HP:0011103) | 3.68762398 |
| 28 | Subaortic stenosis (HP:0001682) | 3.68762398 |
| 29 | Difficulty running (HP:0009046) | 3.64045453 |
| 30 | Abnormal atrioventricular conduction (HP:0005150) | 3.62447291 |
| 31 | Ventricular arrhythmia (HP:0004308) | 3.62283150 |
| 32 | Atrioventricular block (HP:0001678) | 3.58644460 |
| 33 | Increased connective tissue (HP:0009025) | 3.47392204 |
| 34 | Hepatic necrosis (HP:0002605) | 3.41833031 |
| 35 | Muscle fiber inclusion bodies (HP:0100299) | 3.35163724 |
| 36 | Rhabdomyolysis (HP:0003201) | 3.31733330 |
| 37 | Myotonia (HP:0002486) | 3.27287882 |
| 38 | Acute encephalopathy (HP:0006846) | 3.26764617 |
| 39 | Centrally nucleated skeletal muscle fibers (HP:0003687) | 3.24010231 |
| 40 | Ventricular fibrillation (HP:0001663) | 3.22090135 |
| 41 | Deep venous thrombosis (HP:0002625) | 3.17251681 |
| 42 | Muscle fiber cytoplasmatic inclusion bodies (HP:0100303) | 3.15324195 |
| 43 | Progressive macrocephaly (HP:0004481) | 3.05593381 |
| 44 | Pheochromocytoma (HP:0002666) | 2.98762460 |
| 45 | Distal lower limb muscle weakness (HP:0009053) | 2.98672691 |
| 46 | Hepatocellular necrosis (HP:0001404) | 2.96532476 |
| 47 | Ketoacidosis (HP:0001993) | 2.94682118 |
| 48 | Left ventricular hypertrophy (HP:0001712) | 2.88159612 |
| 49 | Abnormal EKG (HP:0003115) | 2.83741636 |
| 50 | Hypoglycemic coma (HP:0001325) | 2.81205648 |
| 51 | Mitochondrial inheritance (HP:0001427) | 2.78718297 |
| 52 | Increased variability in muscle fiber diameter (HP:0003557) | 2.74892873 |
| 53 | Cerebral edema (HP:0002181) | 2.73516646 |
| 54 | Nemaline bodies (HP:0003798) | 2.72729057 |
| 55 | Abnormality of dicarboxylic acid metabolism (HP:0010995) | 2.68265004 |
| 56 | Dicarboxylic aciduria (HP:0003215) | 2.68265004 |
| 57 | Increased CSF lactate (HP:0002490) | 2.67337448 |
| 58 | Neuroendocrine neoplasm (HP:0100634) | 2.61826262 |
| 59 | Bulbar palsy (HP:0001283) | 2.61737809 |
| 60 | Abnormality of pyruvate family amino acid metabolism (HP:0010915) | 2.59006868 |
| 61 | Abnormality of alanine metabolism (HP:0010916) | 2.59006868 |
| 62 | Hyperalaninemia (HP:0003348) | 2.59006868 |
| 63 | Difficulty climbing stairs (HP:0003551) | 2.58910557 |
| 64 | Mildly elevated creatine phosphokinase (HP:0008180) | 2.57695475 |
| 65 | Type 1 muscle fiber predominance (HP:0003803) | 2.56553552 |
| 66 | Abnormality of skeletal muscle fiber size (HP:0012084) | 2.54172548 |
| 67 | Muscle stiffness (HP:0003552) | 2.53664662 |
| 68 | Abnormality of fatty-acid metabolism (HP:0004359) | 2.45358978 |
| 69 | Areflexia of lower limbs (HP:0002522) | 2.43710821 |
| 70 | Limb-girdle muscle atrophy (HP:0003797) | 2.42299291 |
| 71 | Palmoplantar keratoderma (HP:0000982) | 2.42008103 |
| 72 | Distal lower limb amyotrophy (HP:0008944) | 2.41993848 |
| 73 | Increased muscle lipid content (HP:0009058) | 2.40550129 |
| 74 | Rimmed vacuoles (HP:0003805) | 2.39965580 |
| 75 | Myopathic facies (HP:0002058) | 2.38174149 |
| 76 | Gowers sign (HP:0003391) | 2.37414096 |
| 77 | Neck muscle weakness (HP:0000467) | 2.33497454 |
| 78 | Respiratory failure (HP:0002878) | 2.31849034 |
| 79 | Conjunctival hamartoma (HP:0100780) | 2.31567643 |
| 80 | Frequent falls (HP:0002359) | 2.29554509 |
| 81 | Exercise intolerance (HP:0003546) | 2.26776256 |
| 82 | Lactic acidosis (HP:0003128) | 2.24759872 |
| 83 | Foot dorsiflexor weakness (HP:0009027) | 2.17031205 |
| 84 | Increased intramyocellular lipid droplets (HP:0012240) | 2.16565497 |
| 85 | Ketosis (HP:0001946) | 2.14341833 |
| 86 | Abnormality of the foot musculature (HP:0001436) | 2.12455528 |
| 87 | Flat acetabular roof (HP:0003180) | 2.12446743 |
| 88 | Bradycardia (HP:0001662) | 2.07944149 |
| 89 | Round ear (HP:0100830) | 2.07451404 |
| 90 | Central scotoma (HP:0000603) | 2.06862152 |
| 91 | Lower limb amyotrophy (HP:0007210) | 2.05418368 |
| 92 | Hypoalphalipoproteinemia (HP:0003233) | 2.04450198 |
| 93 | Abnormality of the shoulder girdle musculature (HP:0001435) | 2.00968097 |
| 94 | Neoplasm of head and neck (HP:0012288) | 1.99373386 |
| 95 | Esophageal neoplasm (HP:0100751) | 1.99373386 |
| 96 | Sudden cardiac death (HP:0001645) | 1.98499393 |
| 97 | Nausea (HP:0002018) | 1.98347320 |
| 98 | Hyperinsulinemic hypoglycemia (HP:0000825) | 1.98202924 |
| 99 | Progressive muscle weakness (HP:0003323) | 1.97855866 |
| 100 | Distal upper limb amyotrophy (HP:0007149) | 1.96956253 |
| 101 | Upper limb amyotrophy (HP:0009129) | 1.96956253 |
| 102 | Facial diplegia (HP:0001349) | 1.96487989 |
| 103 | Neoplasm of the adrenal gland (HP:0100631) | 1.92528906 |
| 104 | Abnormality of glycolysis (HP:0004366) | 1.92466087 |
| 105 | Increased serum pyruvate (HP:0003542) | 1.92466087 |
| 106 | Ulnar deviation of the wrist (HP:0003049) | 1.91038045 |
| 107 | Skin nodule (HP:0200036) | 1.90959362 |
| 108 | Neonatal death (HP:0003811) | 1.90660219 |
| 109 | Ragged-red muscle fibers (HP:0003200) | 1.90318442 |
| 110 | Muscular dystrophy (HP:0003560) | 1.88544823 |
| 111 | Athetosis (HP:0002305) | 1.88310174 |
| 112 | Spinal rigidity (HP:0003306) | 1.84337830 |
| 113 | Generalized aminoaciduria (HP:0002909) | 1.83165714 |
| 114 | Scapular winging (HP:0003691) | 1.83053387 |
| 115 | Hamartoma of the eye (HP:0010568) | 1.81886409 |
| 116 | EMG: neuropathic changes (HP:0003445) | 1.80012838 |
| 117 | Dysmetric saccades (HP:0000641) | 1.79959387 |
| 118 | Joint hemorrhage (HP:0005261) | 1.79657840 |
| 119 | Congestive heart failure (HP:0001635) | 1.78727857 |
| 120 | Abnormality of the tricuspid valve (HP:0001702) | 1.78064200 |
| 121 | Back pain (HP:0003418) | 1.77215163 |
| 122 | Nuclear cataract (HP:0100018) | 1.75103458 |
| 123 | Generalized muscle weakness (HP:0003324) | 1.74021116 |
| 124 | Hypercholesterolemia (HP:0003124) | 1.70810880 |
| 125 | Aneurysm (HP:0002617) | 1.69046023 |
| 126 | Partial duplication of thumb phalanx (HP:0009944) | 1.68608787 |
| 127 | Abnormality of pain sensation (HP:0010832) | 1.66822020 |
| 128 | Impaired pain sensation (HP:0007328) | 1.66822020 |
| 129 | Proximal amyotrophy (HP:0007126) | 1.64219075 |
| 130 | Axonal loss (HP:0003447) | 1.64129441 |
| 131 | Achilles tendon contracture (HP:0001771) | 1.62271781 |
| 132 | Abnormality of the Achilles tendon (HP:0005109) | 1.61453684 |
| 133 | Cerebral aneurysm (HP:0004944) | 1.61284759 |
| 134 | Myocardial infarction (HP:0001658) | 1.60907504 |
| 135 | Malignant hyperthermia (HP:0002047) | 1.58779952 |
| 136 | Esophageal varix (HP:0002040) | 1.57517186 |
| 137 | Easy fatigability (HP:0003388) | 1.56134386 |
| 138 | Complement deficiency (HP:0004431) | 1.56107604 |

| Rank | Gene Set | Z-score |
|---|---|---|
| 1 | TTN | 6.79519206 |
| 2 | OBSCN | 4.60951161 |
| 3 | IRAK3 | 4.27656760 |
| 4 | PHKG2 | 3.98089785 |
| 5 | PHKG1 | 3.98089785 |
| 6 | LMTK2 | 3.68951599 |
| 7 | PDK4 | 3.41302054 |
| 8 | PDK3 | 3.41302054 |
| 9 | MST1R | 3.25690165 |
| 10 | MYLK | 3.08406646 |
| 11 | DMPK | 3.05678843 |
| 12 | MUSK | 2.35996046 |
| 13 | PINK1 | 2.30071782 |
| 14 | PDK2 | 2.27259966 |
| 15 | PKN2 | 2.21793462 |
| 16 | CDK12 | 2.06888963 |
| 17 | MET | 2.04372495 |
| 18 | EEF2K | 1.98514272 |
| 19 | EPHA2 | 1.95824176 |
| 20 | GRK7 | 1.90609159 |
| 21 | TAOK2 | 1.76491864 |
| 22 | PAK3 | 1.76476421 |
| 23 | SMG1 | 1.71222215 |
| 24 | BCKDK | 1.69058751 |
| 25 | TRIB3 | 1.68408894 |
| 26 | STK24 | 1.67718192 |
| 27 | PIK3CA | 1.62802103 |
| 28 | ERN1 | 1.58877041 |
| 29 | TAOK1 | 1.55319358 |
| 30 | CAMK2D | 1.54246058 |
| 31 | TIE1 | 1.51103841 |
| 32 | NEK1 | 1.47980013 |
| 33 | FGFR4 | 1.43867954 |
| 34 | MAP3K3 | 1.39691328 |
| 35 | SIK1 | 1.38047715 |
| 36 | EPHB1 | 1.34811762 |
| 37 | PRKD1 | 1.32427600 |
| 38 | ARAF | 1.31638073 |
| 39 | DDR2 | 1.25134782 |
| 40 | TYRO3 | 1.23460815 |
| 41 | PKN1 | 1.19453871 |
| 42 | STK39 | 1.15519580 |
| 43 | BMX | 1.14096154 |
| 44 | MAP3K7 | 1.14051774 |
| 45 | MAP3K10 | 1.05278039 |
| 46 | CAMK2A | 1.05148884 |
| 47 | MTOR | 1.04881412 |
| 48 | ILK | 1.00195971 |
| 49 | MAPK12 | 0.96713122 |
| 50 | WNK4 | 0.96181351 |
| 51 | EPHB2 | 0.95331934 |
| 52 | PTK2 | 0.94459792 |
| 53 | ROCK1 | 0.90624602 |
| 54 | PAK4 | 0.87943909 |
| 55 | ROCK2 | 0.86008351 |
| 56 | PRKAA2 | 0.82837765 |
| 57 | EPHA3 | 0.82014710 |
| 58 | CAMK4 | 0.80577213 |
| 59 | CDC42BPA | 0.80157908 |
| 60 | KSR2 | 0.79866614 |
| 61 | TBK1 | 0.79654439 |
| 62 | IRAK2 | 0.78546932 |
| 63 | PIM2 | 0.76541874 |
| 64 | PTK2B | 0.76236192 |
| 65 | CAMK2G | 0.74583155 |
| 66 | PRKAA1 | 0.74177779 |
| 67 | AKT2 | 0.73792724 |
| 68 | ERBB4 | 0.72974112 |
| 69 | CDK9 | 0.72401842 |
| 70 | DAPK3 | 0.72401484 |
| 71 | RIPK1 | 0.68494628 |
| 72 | MAP3K11 | 0.66114450 |
| 73 | WNK1 | 0.65862356 |
| 74 | PAK6 | 0.64468002 |
| 75 | CAMK1 | 0.63910509 |
| 76 | BRAF | 0.63497704 |
| 77 | FGFR3 | 0.60952070 |
| 78 | STK4 | 0.58131493 |
| 79 | PRKCE | 0.57511924 |
| 80 | MAP2K4 | 0.56847181 |
| 81 | MAP3K5 | 0.55876629 |
| 82 | ALK | 0.55551547 |
| 83 | PRPF4B | 0.53127425 |
| 84 | MAP3K13 | 0.53037724 |
| 85 | PRKACB | 0.52182893 |
| 86 | TRPM7 | 0.51221051 |
| 87 | CAMK2B | 0.51119698 |
| 88 | PDGFRA | 0.50860118 |
| 89 | MELK | 0.50667599 |
| 90 | INSRR | 0.50305052 |
| 91 | TNIK | 0.49786603 |
| 92 | RET | 0.48594536 |
| 93 | TGFBR2 | 0.47940806 |
| 94 | STK38 | 0.47306274 |
| 95 | CDK8 | 0.46226955 |
| 96 | SGK3 | 0.45834962 |
| 97 | MAPK4 | 0.45753980 |
| 98 | LATS2 | 0.45659217 |
| 99 | FGR | 0.45614467 |
| 100 | ICK | 0.44519236 |
| 101 | MAP3K4 | 0.43210733 |
| 102 | PDPK1 | 0.42932242 |
| 103 | PRKACA | 0.42100087 |
| 104 | MAP3K1 | 0.42011563 |
| 105 | MAPKAPK3 | 0.41624735 |
| 106 | NTRK3 | 0.41076773 |
| 107 | PIK3CG | 0.40426274 |
| 108 | RPS6KA1 | 0.40371247 |
| 109 | MAP3K8 | 0.40071201 |
| 110 | NEK9 | 0.39596350 |
| 111 | RPS6KB2 | 0.39543583 |
| 112 | LATS1 | 0.38284377 |
| 113 | CLK1 | 0.37797842 |
| 114 | PDK1 | 0.37468122 |
| 115 | MAPKAPK2 | 0.37376364 |
| 116 | PRKCH | 0.36725928 |
| 117 | MAP2K3 | 0.36426918 |
| 118 | NME1 | 0.34546815 |
| 119 | MOS | 0.33484962 |
| 120 | MAPK11 | 0.33330447 |
| 121 | MATK | 0.33063373 |
| 122 | PRKACG | 0.33058433 |
| 123 | MARK1 | 0.32443006 |
| 124 | EPHA4 | 0.32382854 |
| 125 | AURKA | 0.29908909 |
| 126 | CAMK1D | 0.29378215 |
| 127 | STK38L | 0.29369671 |
| 128 | NME2 | 0.29034984 |
| 129 | PRKG1 | 0.28557106 |
| 130 | CDK4 | 0.28545744 |
| 131 | UHMK1 | 0.28541282 |
| 132 | SGK1 | 0.28318755 |
| 133 | MARK2 | 0.27629828 |
| 134 | PDGFRB | 0.26185851 |
| 135 | MAP3K6 | 0.26077564 |
| 136 | RPS6KA6 | 0.25695438 |
| 137 | RPS6KA2 | 0.25653473 |
| 138 | FER | 0.25635321 |
| 139 | ABL2 | 0.25543823 |
| 140 | GRK5 | 0.24841160 |
| 141 | RPS6KA3 | 0.23247067 |
| 142 | PRKD2 | 0.23231204 |
| 143 | RPS6KL1 | 0.22646804 |
| 144 | RPS6KC1 | 0.22646804 |
| 145 | PRKG2 | 0.20741804 |
| 146 | MAP3K9 | 0.20728072 |
| 147 | LIMK1 | 0.19755448 |
| 148 | FLT3 | 0.19294824 |
| 149 | ADRBK1 | 0.19032470 |
| 150 | CASK | 0.18577144 |
| 151 | NTRK2 | 0.18205140 |
| 152 | MAP2K1 | 0.17591353 |

| Rank | Gene Set | Z-score |
|---|---|---|
| 1 | Citrate cycle (TCA cycle)_Homo sapiens_hsa00020 | 5.35253762 |
| 2 | Cardiac muscle contraction_Homo sapiens_hsa04260 | 4.07807911 |
| 3 | 2-Oxocarboxylic acid metabolism_Homo sapiens_hsa01210 | 3.60008617 |
| 4 | Oxidative phosphorylation_Homo sapiens_hsa00190 | 3.51569943 |
| 5 | Parkinsons disease_Homo sapiens_hsa05012 | 3.40599693 |
| 6 | Dilated cardiomyopathy_Homo sapiens_hsa05414 | 3.38232613 |
| 7 | Propanoate metabolism_Homo sapiens_hsa00640 | 3.21586636 |
| 8 | Hypertrophic cardiomyopathy (HCM)_Homo sapiens_hsa05410 | 3.11199851 |
| 9 | Fatty acid degradation_Homo sapiens_hsa00071 | 2.80153589 |
| 10 | Butirosin and neomycin biosynthesis_Homo sapiens_hsa00524 | 2.68446991 |
| 11 | Alzheimers disease_Homo sapiens_hsa05010 | 2.67585751 |
| 12 | Phenylalanine, tyrosine and tryptophan biosynthesis_Homo sapiens_hsa00400 | 2.67509781 |
| 13 | Valine, leucine and isoleucine degradation_Homo sapiens_hsa00280 | 2.41646858 |
| 14 | Non-alcoholic fatty liver disease (NAFLD)_Homo sapiens_hsa04932 | 2.25491500 |
| 15 | Fatty acid metabolism_Homo sapiens_hsa01212 | 2.20476259 |
| 16 | Arrhythmogenic right ventricular cardiomyopathy (ARVC)_Homo sapiens_hsa05412 | 2.18548345 |
| 17 | Huntingtons disease_Homo sapiens_hsa05016 | 2.11550465 |
| 18 | Carbon metabolism_Homo sapiens_hsa01200 | 2.07797464 |
| 19 | Galactose metabolism_Homo sapiens_hsa00052 | 1.90400154 |
| 20 | Pentose phosphate pathway_Homo sapiens_hsa00030 | 1.83412163 |
| 21 | Synthesis and degradation of ketone bodies_Homo sapiens_hsa00072 | 1.80584513 |
| 22 | Adrenergic signaling in cardiomyocytes_Homo sapiens_hsa04261 | 1.75607866 |
| 23 | Fructose and mannose metabolism_Homo sapiens_hsa00051 | 1.72163913 |
| 24 | Pyruvate metabolism_Homo sapiens_hsa00620 | 1.67845027 |
| 25 | Adherens junction_Homo sapiens_hsa04520 | 1.66516748 |
| 26 | Other glycan degradation_Homo sapiens_hsa00511 | 1.66082635 |
| 27 | Butanoate metabolism_Homo sapiens_hsa00650 | 1.65631837 |
| 28 | Fatty acid elongation_Homo sapiens_hsa00062 | 1.61904184 |
| 29 | Complement and coagulation cascades_Homo sapiens_hsa04610 | 1.47437368 |
| 30 | Viral myocarditis_Homo sapiens_hsa05416 | 1.31594672 |
| 31 | Glyoxylate and dicarboxylate metabolism_Homo sapiens_hsa00630 | 1.28422277 |
| 32 | Bladder cancer_Homo sapiens_hsa05219 | 1.22149693 |
| 33 | Prion diseases_Homo sapiens_hsa05020 | 1.17836419 |
| 34 | cGMP-PKG signaling pathway_Homo sapiens_hsa04022 | 1.05686248 |
| 35 | Glycosaminoglycan degradation_Homo sapiens_hsa00531 | 1.05279188 |
| 36 | Calcium signaling pathway_Homo sapiens_hsa04020 | 0.98828369 |
| 37 | Oxytocin signaling pathway_Homo sapiens_hsa04921 | 0.93442878 |
| 38 | Proteoglycans in cancer_Homo sapiens_hsa05205 | 0.92767781 |
| 39 | Glycolysis / Gluconeogenesis_Homo sapiens_hsa00010 | 0.90655037 |
| 40 | Vascular smooth muscle contraction_Homo sapiens_hsa04270 | 0.90446192 |
| 41 | PPAR signaling pathway_Homo sapiens_hsa03320 | 0.88607317 |
| 42 | Notch signaling pathway_Homo sapiens_hsa04330 | 0.87573830 |
| 43 | Glucagon signaling pathway_Homo sapiens_hsa04922 | 0.85840502 |
| 44 | Arginine and proline metabolism_Homo sapiens_hsa00330 | 0.84933513 |
| 45 | Adipocytokine signaling pathway_Homo sapiens_hsa04920 | 0.83638255 |
| 46 | TNF signaling pathway_Homo sapiens_hsa04668 | 0.82350245 |
| 47 | Glycosaminoglycan biosynthesis - chondroitin sulfate / dermatan sulfate_Homo sapiens_hsa00532 | 0.81521263 |
| 48 | Chronic myeloid leukemia_Homo sapiens_hsa05220 | 0.81386838 |
| 49 | beta-Alanine metabolism_Homo sapiens_hsa00410 | 0.81191144 |
| 50 | Arginine biosynthesis_Homo sapiens_hsa00220 | 0.79811731 |
| 51 | Circadian entrainment_Homo sapiens_hsa04713 | 0.77850153 |
| 52 | Insulin resistance_Homo sapiens_hsa04931 | 0.74380784 |
| 53 | Biosynthesis of amino acids_Homo sapiens_hsa01230 | 0.73081286 |
| 54 | Renin secretion_Homo sapiens_hsa04924 | 0.71906780 |
| 55 | Gastric acid secretion_Homo sapiens_hsa04971 | 0.70717492 |
| 56 | Leukocyte transendothelial migration_Homo sapiens_hsa04670 | 0.69286410 |
| 57 | Starch and sucrose metabolism_Homo sapiens_hsa00500 | 0.68369372 |
| 58 | Insulin secretion_Homo sapiens_hsa04911 | 0.68185648 |
| 59 | Salmonella infection_Homo sapiens_hsa05132 | 0.67583589 |
| 60 | cAMP signaling pathway_Homo sapiens_hsa04024 | 0.66638756 |
| 61 | Toll-like receptor signaling pathway_Homo sapiens_hsa04620 | 0.66106361 |
| 62 | Regulation of lipolysis in adipocytes_Homo sapiens_hsa04923 | 0.64179443 |
| 63 | Nicotinate and nicotinamide metabolism_Homo sapiens_hsa00760 | 0.63965861 |
| 64 | Salivary secretion_Homo sapiens_hsa04970 | 0.62807337 |
| 65 | Tryptophan metabolism_Homo sapiens_hsa00380 | 0.62659471 |
| 66 | Morphine addiction_Homo sapiens_hsa05032 | 0.62414833 |
| 67 | AGE-RAGE signaling pathway in diabetic complications_Homo sapiens_hsa04933 | 0.62167071 |
| 68 | Insulin signaling pathway_Homo sapiens_hsa04910 | 0.62108264 |
| 69 | NF-kappa B signaling pathway_Homo sapiens_hsa04064 | 0.60711786 |
| 70 | Malaria_Homo sapiens_hsa05144 | 0.60232730 |
| 71 | mTOR signaling pathway_Homo sapiens_hsa04150 | 0.60176669 |
| 72 | Type II diabetes mellitus_Homo sapiens_hsa04930 | 0.59329232 |
| 73 | Fatty acid biosynthesis_Homo sapiens_hsa00061 | 0.58975789 |
| 74 | Ubiquinone and other terpenoid-quinone biosynthesis_Homo sapiens_hsa00130 | 0.58412019 |
| 75 | Ovarian steroidogenesis_Homo sapiens_hsa04913 | 0.57404211 |
| 76 | Pancreatic cancer_Homo sapiens_hsa05212 | 0.57377618 |
| 77 | Retrograde endocannabinoid signaling_Homo sapiens_hsa04723 | 0.57375555 |
| 78 | Neurotrophin signaling pathway_Homo sapiens_hsa04722 | 0.57107339 |
| 79 | Peroxisome_Homo sapiens_hsa04146 | 0.56123582 |
| 80 | Lysosome_Homo sapiens_hsa04142 | 0.53480989 |
| 81 | Small cell lung cancer_Homo sapiens_hsa05222 | 0.52336674 |
| 82 | HIF-1 signaling pathway_Homo sapiens_hsa04066 | 0.52110428 |
| 83 | Lysine degradation_Homo sapiens_hsa00310 | 0.52068358 |
| 84 | Olfactory transduction_Homo sapiens_hsa04740 | 0.50122446 |
| 85 | Focal adhesion_Homo sapiens_hsa04510 | 0.49781376 |
| 86 | Taste transduction_Homo sapiens_hsa04742 | 0.49450303 |
| 87 | Bacterial invasion of epithelial cells_Homo sapiens_hsa05100 | 0.48862702 |
| 88 | Pertussis_Homo sapiens_hsa05133 | 0.48565651 |
| 89 | Thyroid cancer_Homo sapiens_hsa05216 | 0.48181631 |
| 90 | Aldosterone synthesis and secretion_Homo sapiens_hsa04925 | 0.48106862 |
| 91 | GABAergic synapse_Homo sapiens_hsa04727 | 0.48046400 |
| 92 | Longevity regulating pathway - multiple species_Homo sapiens_hsa04213 | 0.47691805 |
| 93 | FoxO signaling pathway_Homo sapiens_hsa04068 | 0.46574070 |
| 94 | Biosynthesis of unsaturated fatty acids_Homo sapiens_hsa01040 | 0.46210198 |
| 95 | AMPK signaling pathway_Homo sapiens_hsa04152 | 0.45864642 |
| 96 | GnRH signaling pathway_Homo sapiens_hsa04912 | 0.45793664 |
| 97 | Dorso-ventral axis formation_Homo sapiens_hsa04320 | 0.44461267 |
| 98 | ErbB signaling pathway_Homo sapiens_hsa04012 | 0.42409390 |
| 99 | Glycine, serine and threonine metabolism_Homo sapiens_hsa00260 | 0.42404354 |
| 100 | Legionellosis_Homo sapiens_hsa05134 | 0.42385481 |
| 101 | Amino sugar and nucleotide sugar metabolism_Homo sapiens_hsa00520 | 0.42069307 |
| 102 | Glutamatergic synapse_Homo sapiens_hsa04724 | 0.42067814 |
| 103 | Cholinergic synapse_Homo sapiens_hsa04725 | 0.39351724 |
| 104 | Apoptosis_Homo sapiens_hsa04210 | 0.38642251 |
| 105 | Hepatitis C_Homo sapiens_hsa05160 | 0.37374442 |
| 106 | Circadian rhythm_Homo sapiens_hsa04710 | 0.37168718 |
| 107 | MicroRNAs in cancer_Homo sapiens_hsa05206 | 0.36846386 |
| 108 | Acute myeloid leukemia_Homo sapiens_hsa05221 | 0.36130665 |
| 109 | Protein processing in endoplasmic reticulum_Homo sapiens_hsa04141 | 0.36100393 |
| 110 | Cyanoamino acid metabolism_Homo sapiens_hsa00460 | 0.35839302 |
| 111 | Renal cell carcinoma_Homo sapiens_hsa05211 | 0.35414997 |
| 112 | Long-term potentiation_Homo sapiens_hsa04720 | 0.35194380 |
| 113 | Glutathione metabolism_Homo sapiens_hsa00480 | 0.35089100 |
| 114 | Gap junction_Homo sapiens_hsa04540 | 0.34358255 |
| 115 | Thyroid hormone signaling pathway_Homo sapiens_hsa04919 | 0.34121902 |
| 116 | Tight junction_Homo sapiens_hsa04530 | 0.34091740 |
| 117 | Chagas disease (American trypanosomiasis)_Homo sapiens_hsa05142 | 0.33176849 |
| 118 | Endometrial cancer_Homo sapiens_hsa05213 | 0.32850822 |
| 119 | Glycosaminoglycan biosynthesis - heparan sulfate / heparin_Homo sapiens_hsa00534 | 0.32380018 |
| 120 | Pancreatic secretion_Homo sapiens_hsa04972 | 0.31427176 |
| 121 | ECM-receptor interaction_Homo sapiens_hsa04512 | 0.30766233 |
| 122 | Pentose and glucuronate interconversions_Homo sapiens_hsa00040 | 0.30594867 |
| 123 | Endocrine and other factor-regulated calcium reabsorption_Homo sapiens_hsa04961 | 0.29339783 |
| 124 | Osteoclast differentiation_Homo sapiens_hsa04380 | 0.28881155 |
| 125 | Regulation of actin cytoskeleton_Homo sapiens_hsa04810 | 0.28132808 |
| 126 | Alanine, aspartate and glutamate metabolism_Homo sapiens_hsa00250 | 0.27729745 |
| 127 | Hippo signaling pathway_Homo sapiens_hsa04390 | 0.26747405 |
| 128 | Axon guidance_Homo sapiens_hsa04360 | 0.26405601 |
| 129 | Longevity regulating pathway - mammal_Homo sapiens_hsa04211 | 0.24947495 |
| 130 | Metabolic pathways_Homo sapiens_hsa01100 | 0.24569496 |
| 131 | Phenylalanine metabolism_Homo sapiens_hsa00360 | 0.23485689 |
| 132 | Estrogen signaling pathway_Homo sapiens_hsa04915 | 0.23408081 |
| 133 | Vasopressin-regulated water reabsorption_Homo sapiens_hsa04962 | 0.21818795 |
| 134 | Platelet activation_Homo sapiens_hsa04611 | 0.20601645 |
| 135 | VEGF signaling pathway_Homo sapiens_hsa04370 | 0.19740890 |
| 136 | alpha-Linolenic acid metabolism_Homo sapiens_hsa00592 | 0.19168456 |
| 137 | MAPK signaling pathway_Homo sapiens_hsa04010 | 0.18775688 |
| 138 | Dopaminergic synapse_Homo sapiens_hsa04728 | 0.18719584 |
| 139 | Serotonergic synapse_Homo sapiens_hsa04726 | 0.18463929 |
| 140 | Phospholipase D signaling pathway_Homo sapiens_hsa04072 | 0.17937724 |
| 141 | Bile secretion_Homo sapiens_hsa04976 | 0.17180605 |
| 142 | Amoebiasis_Homo sapiens_hsa05146 | 0.16175896 |
| 143 | Central carbon metabolism in cancer_Homo sapiens_hsa05230 | 0.15989499 |
| 144 | Amphetamine addiction_Homo sapiens_hsa05031 | 0.15116491 |
| 145 | Linoleic acid metabolism_Homo sapiens_hsa00591 | 0.14511764 |
| 146 | Nicotine addiction_Homo sapiens_hsa05033 | 0.12817439 |
| 147 | Phosphatidylinositol signaling system_Homo sapiens_hsa04070 | 0.11246607 |
| 148 | Ras signaling pathway_Homo sapiens_hsa04014 | 0.11094719 |

